{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:28:58Z","timestamp":1766125738818,"version":"3.48.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triple-negative breast cancer (TNBC) is defined by the absence of ER, PR, and HER2 expression. This limits the targeted therapies, resulting in poor clinical outcomes. Identifying the molecular targets that can be regulated through miRNAs and natural compounds offers a potential therapeutic platform.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We combined transcriptomic profiling with miRNA target prediction to identify genes regulated by miR-30a-5p and assess their interaction with the green tea polyphenol, epigallocatechin gallate (EGCG). Differentially expressed genes (DEGs) from TCGA-TNBC datasets and miRNA targets from miRDB, TargetScan, and miRTarBase were screened for common genes. Then, the protein-protein interaction and network topology analyses were performed to identify key hub genes. Molecular docking and simulation were carried out with the four key genes against EGCG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data integration yielded 393 overlapping genes and identified ten hub genes-\n                      <jats:italic>RRM2<\/jats:italic>\n                      ,\n                      <jats:italic>KIF11<\/jats:italic>\n                      ,\n                      <jats:italic>ANLN<\/jats:italic>\n                      ,\n                      <jats:italic>CDC20<\/jats:italic>\n                      ,\n                      <jats:italic>CCNA1<\/jats:italic>\n                      ,\n                      <jats:italic>AGO2<\/jats:italic>\n                      ,\n                      <jats:italic>YWHAZ<\/jats:italic>\n                      ,\n                      <jats:italic>DTL<\/jats:italic>\n                      ,\n                      <jats:italic>SKP2<\/jats:italic>\n                      , and\n                      <jats:italic>PCNA<\/jats:italic>\n                      . Pathway enrichment showed that all these hubs are involved in cell cycle and mitotic regulation, which was associated with poor TNBC prognosis. Mutation profiling revealed high alteration rates in\n                      <jats:italic>KIF11<\/jats:italic>\n                      ,\n                      <jats:italic>ANLN, CDC20<\/jats:italic>\n                      , and\n                      <jats:italic>YWHAZ<\/jats:italic>\n                      , with increased missense mutations and C&amp;gt;T transitions. Molecular docking and simulations identified\n                      <jats:italic>YWHAZ<\/jats:italic>\n                      as the most favorable and structurally stable EGCG-binding target, compared to the other three key genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results emphasizes that EGCG has strong binding affinity towards YWHAZ, revealing that miR-30a-EGCG targets TNBC synergistically through cell-cycle-mediated pathways. The findings give rational support for miRNA-guided phytochemical-based TNBC therapeutic development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fbinf.2025.1735106","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:25:14Z","timestamp":1766125514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Network-based insights into miR-30a-5p-mediated regulation and EGCG targeting in triple-negative breast cancer"],"prefix":"10.3389","volume":"5","author":[{"given":"Loganathan Chandramani Priya","family":"Dharshini","sequence":"first","affiliation":[]},{"given":"Abul Kalam Azad","family":"Mandal","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.semcancer.2020.05.011","article-title":"Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement","volume":"80","author":"Aggarwal","year":"2022","journal-title":"Sem. Cancer Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1634\/theoncologist.2014-0002","article-title":"Measures of outcome in metastatic breast cancer: insights from a real-world scenario","volume":"19","author":"Bonotto","year":"2014","journal-title":"Oncologist"},{"key":"B3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1749-8546-5-13","article-title":"Beneficial effects of green tea: a literature review","volume":"5","author":"Chacko","year":"2010","journal-title":"Chin. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.soc.2017.08.004","article-title":"Triple-negative breast cancer: who should receive neoadjuvant chemotherapy?","volume":"27","author":"Chaudhary","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"B5","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","article-title":"miRTarBase 2025: updates to the collection of experimentally validated microRNA-target interactions","volume":"53","author":"Cui","year":"2024","journal-title":"Nucleic Acid. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41419-023-05908-8","article-title":"Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks","volume":"14","author":"Elango","year":"2023","journal-title":"Cell Death Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"25678","DOI":"10.1038\/s41598-025-11592-9","article-title":"System biology-based assessment of the molecular mechanism of epigallocatechin gallate in Parkinson\u2019s disease: via network pharmacology, in-silico evaluation & in-vitro studies","volume":"15","author":"Fanai","year":"2025","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.7150\/jca.41316","article-title":"The role of YWHAZ in cancer: a maze of opportunities and challenges","volume":"11","author":"Gan","year":"2020","journal-title":"J. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2019","journal-title":"Bioinformatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.ajpath.2017.03.016","article-title":"The spectrum of triple-negative breast disease: High- and low-grade lesions","volume":"187","author":"Geyer","year":"2017","journal-title":"A. J. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"118901","DOI":"10.1016\/j.molliq.2022.118901","article-title":"Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review","volume":"354","author":"Ghahremanian","year":"2022","journal-title":"J. Mo. Lipids."},{"key":"B14","doi-asserted-by":"publisher","first-page":"92106","DOI":"10.18632\/oncotarget.20785","article-title":"KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5167829","article-title":"MiR-30a: a novel biomarker and potential therapeutic target for cancer","volume":"2018","author":"Jiang","year":"2018","journal-title":"J. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/life13020422","article-title":"In silico analysis of publicly available transcriptomic data for the identification of triple-negative breast cancer-specific biomarkers","volume":"13","author":"Kaddoura","year":"2023","journal-title":"Life"},{"key":"B64","doi-asserted-by":"publisher","first-page":"9144","DOI":"10.3390\/ijms26189144","article-title":"Exploring the therapeutic potential of epigallocatechin-3-gallate (Green tea) in periodontitis using network pharmacology and molecular modelling approach","volume":"26","author":"Kamaraj","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1038\/bjc.2014.252","article-title":"Cdc20 and securin overexpression predict short-term breast cancer survival","volume":"110","author":"Karra","year":"2014","journal-title":"Brit. J. Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/1759-7714.14928","article-title":"Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p\/YWHAZ axis","volume":"14","author":"Kong","year":"2023","journal-title":"Thorac. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/bab.2700","article-title":"Deciphering the prognostic landscape of triple-negative breast cancer: a focus on immune-related hub genes and therapeutic implications","volume":"72","author":"Krishnamoorthy","year":"2024","journal-title":"Biotechnol. Appl. Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11060-015-1954-3","article-title":"Overexpression of Eg5 correlates with high grade astrocytic neoplasm","volume":"126","author":"Liu","year":"2016","journal-title":"J. Neurooncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13048-020-00722-8","article-title":"Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer","volume":"13","author":"Lu","year":"2020","journal-title":"J. Ovarian Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.3390\/ijms241310737","article-title":"The potential role of epigallocatechin-3-gallate (EGCG) in breast cancer treatment","volume":"24","author":"Marin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"700973","DOI":"10.3389\/fmolb.2021.700973","article-title":"ANLN enhances triple-negative breast cancer stemness through TWIST1 and BMP2 and promotes its spheroid growth","volume":"8","author":"Maryam","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/cncr.22836","article-title":"Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the national cancer Institute\u2019s surveillance, epidemiology, and end results database","volume":"110","author":"Morris","year":"2007","journal-title":"Cancer"},{"key":"B28","unstructured":"An interactive tool for comparing lists with Venn\u2019s diagrams\n          \n          \n            \n              Oliveros\n              J. C.\n            \n          \n          \n          2007"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/bab.70039","article-title":"Unraveling the complexities in TNBC gene interaction networks towards better therapeutics","volume":"2025","author":"Paranthaman","year":"2025","journal-title":"Biotechnol. Appl. Biochem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"710337","DOI":"10.3389\/fonc.2021.710337","article-title":"miRNome and functional network analysis of PGRMC1 regulated miRNA target genes identify pathways and biological functions associated with triple negative breast cancer","volume":"11","author":"Pedroza","year":"2021","journal-title":"Front. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.semcdb.2010.08.002","article-title":"The myriad roles of anillin during cytokinesis","volume":"21","author":"Piekny","year":"2010","journal-title":"Sem. Cell Dev. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/pharmaceutics15010246","article-title":"Recent advances in targeted nanocarriers for the management of triple negative breast cancer","volume":"15","author":"Pradhan","year":"2023","journal-title":"Pharmaceutics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversion of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2174\/1389557520999201211194445","article-title":"The role of EGCG in breast cancer prevention and therapy","volume":"21","author":"Romano","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/diagnostics13010127","article-title":"The role of miRNAs in the prognosis of triple-negative breast cancer: a systematic review and meta-analysis","volume":"13","author":"Santana","year":"2023","journal-title":"Diagnostics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Scklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2413089121","DOI":"10.1073\/pnas.2413089121","article-title":"The mitotic checkpoint complex controls the association of Cdc20 regulatory protein with the ubiquitin ligase APC\/C in mitosis","volume":"121","author":"Sitry-Shevah","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s12282-021-01242-z","article-title":"Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)","volume":"28","author":"Song","year":"2021","journal-title":"Breast Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3390\/ijms22031422","article-title":"Current achievements and applications of transcriptomics in personalized cancer medicine","volume":"22","author":"Supplitt","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acid. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41419-024-06651-4","article-title":"RUVBL1 ubiquitination by DTL promotes RUVBL1\/2-\u03b2-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer","volume":"15","author":"Tian","year":"2024","journal-title":"Cell Death Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1471-2407-9-196","article-title":"KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?","volume":"9","author":"Valensin","year":"2009","journal-title":"BMC Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gki005","article-title":"STRING: known and predicted protein-protein associations, integrated and transferred across organisms","volume":"33","author":"Von Mering","year":"2004","journal-title":"Nucleic Acid. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","article-title":"Targeting Cdc20 as a novel cancer therapeutic strategy","volume":"151","author":"Wang","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e3071","DOI":"10.1038\/cddis.2017.460","article-title":"Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/molecules24071445","article-title":"In silico investigation of the anti-tumor mechanisms of epigallocatechin-3-gallate","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1445034","DOI":"10.3389\/fphar.2024.1445034","article-title":"The role of the miR-30a-5p\/BCL2L11 pathway in rosmarinic acid-induced apoptosis in MDA-MB-231-derived breast cancer stem-like cells","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12967-025-06081-6","article-title":"Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1535-7163.mct-20-0373","article-title":"Molecular targeting of RRM2, NF-\u03baB, and mutant TP53 for the treatment of triple-negative breast cancer","volume":"20","author":"Wilson","year":"2021","journal-title":"Small Mol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/jco.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/cts.12470","article-title":"Bioinformatics analysis on molecular mechanism of green tea compound epigallocatechin-3-gallate against ovarian cancer","volume":"10","author":"Xinqiang","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.03.069","article-title":"MiR-30a-5p\/UBE3C axis regulates breast cancer cell proliferation and migration","volume":"516","author":"Xiong","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s12672-025-02365-x","article-title":"An integrative analysis combining bioinformatics, network pharmacology and experimental methods identified key genes of EGCG targets in Nasopharyngeal carcinoma","volume":"16","author":"Yang","year":"2025","journal-title":"Discov. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"Npj Breast Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.7150\/ijbs.64628","article-title":"Post-translational modifications of PCNA in control of DNA synthesis and DNA damage tolerance-the implications in carcinogenesis","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"bbac384","DOI":"10.1093\/bib\/bbac384","article-title":"A geometric deep learning framework for drug repositioning over heterogeneous information networks","volume":"23","author":"Zhao","year":"2022","journal-title":"Brief. Bioinfo."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.csbj.2024.06.032","article-title":"A heterogeneous information network learning model with neighborhood-level structural representation for predicting lncRNA-miRNA interactions","volume":"23","author":"Zhao","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12920-017-0300-3","article-title":"Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN","volume":"10","author":"Zhong","year":"2017","journal-title":"BMC Med. Genomics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11010-014-2200-6","article-title":"Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer","volume":"398","author":"Zhou","year":"2015","journal-title":"Mol. Cell Biochem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4143\/crt.2018.460","article-title":"KIF11 functions as an oncogene and is associated with poor outcomes from breast cancer","volume":"51","author":"Zhou","year":"2019","journal-title":"Cancer Res. Treat."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1735106\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:25:17Z","timestamp":1766125517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1735106\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":64,"alternative-id":["10.3389\/fbinf.2025.1735106"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1735106","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"article-number":"1735106"}}